GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer

WEDNESDAY, April 24, 2024-- Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to be associated with an increased risk for thyroid cancer, according to a study published online April 10 in The BMJ.Björn Pasternak, M.D., Ph.D.,...